Taner Kasar

Dr. Taner Kasar

, Istanbul Saglik Bilimleri University Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Education and Research Hospital, Istanbul, İstanbul, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2018 in Polish Heart Journal
Verified
Journal Article
Closed access
PDF file
TKTaner Kasar
Taner Kasar
HKHasan Candaş Kafalı
Hasan Candaş Kafalı
ATAysel Türkvatan
Aysel Türkvatan
YEYakup Ergül
Yakup Ergül

1 January 2018 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
TKTaner Kasar
Taner Kasar

1 May 2019 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
TKTaner Kasar
Taner Kasar
HKH. Candas Kafali
H. Candas Kafali
YEYakup Ergul
Yakup Ergul
The coexistence of long QT syndrome with 2:1 or complete atrioventricular blocks has been reported in the literature, but, to the best of our knowledge, this is the first pediatric case of long QT syndrome coexisting with first-degree atrioventricular blocks(1–3).

23 December 2022 in Medicine
Verified
Journal Article
Open access
TKTaner Kasar
Taner Kasar
OEOzturk Erkut
Ozturk Erkut
ITİ. Cansaran Tanidir
İ. Cansaran Tanidir
MŞMurat Şahin
Murat Şahin
MTM. Akin Topkarci
M. Akin Topkarci
AGAlper Guzeltas
Alper Guzeltas
Although balloon-expandable stent implantation for native aortic coarctation is a preferred method in the adolescent age group, there are insufficient data about indications for and the efficacy of the procedure in a younger age group. The aim of this study was to compare and evaluate the data of young pediatric and adolescent patients who underwent balloon-expandable stent implantation because of native aortic coarctation. The retrospective analysis included the demographic characteristics and data related to the procedure and follow-up of patients who underwent stent implantation for native aortic coarctation between August 2010 and November 2017. Patients with re-coarctation were excluded from the study. The patients were separated into 2 groups as the adolescent group (Group I: 10–18 years) and the pediatric group (Group II: ≤ 9.9 years). Group-I comprised of 18 patients and Group-II, 32 patients. Covered stent was implanted to 32 (73%) patients and uncovered stent to 12 (27%) patients. The procedural success rate was 100%. Following stent implantation, peak systolic gradient decreased significantly in both groups (P < .0001) (Group-I: from 35.9 ± 16.6 mm Hg–2.2 ± 3.4 mm Hg, Group II: from 34 ± 13.3 mm Hg–3 ± 4.09 mm Hg). Complications developed in 3 patients, and all in Group I. Femoral hematoma developed in 1 patient, balloon rupture occurred during the procedure in 1 patient, and there was temporary loss of pulse in 1 patient. All the complications were treated successfully. All the patients were taking anti-hypertensive drugs before intervention and during the mean 23-month follow-up period (range, 2–84 months), hypertension recovered in 35 (80%) patients and drugs were terminated. Stent implantation for aortic coarctation in the pediatric age group may provide pleasing results, reducing the coarctation gradient, providing effective dilatation in the lesion area and eliminating hypertension.

1 July 2020 in Revista Portuguesa de Cardiologia
Verified
Journal Article
Open access
TKTaner Kasar
Taner Kasar
EOErkut Ozturk
Erkut Ozturk
PAPelin Ayyıldız
Pelin Ayyıldız
YEYakup Ergul
Yakup Ergul
AGAlper Guzeltas
Alper Guzeltas
Congenitally corrected transposition of the great arteries (ccTGA) is a rare congenital heart defect. There are different subgroups according to the location of the heart in the thorax, apical position and situs. The purpose of this study was to assess pediatric patients with situs inversus (SI) ccTGA (SI-ccTGA), a rare subgroup of this condition, in detail. The records of patients with SI-ccTGA followed between January 1, 2010 and January 1, 2019 in our clinic were analyzed retrospectively. Demographic features, associated cardiac defects, arrhythmias and follow-up data were recorded. Twenty-one out of 120 ccTGA patients had SI. The median age was 30 months (4 days-18 years). There were hemodynamically significant associated lesions in 85.7% (n=18) of the patients. A large ventricular septal defect was found in 16 patients (76.2%), severe pulmonary stenosis in 11 (52.4%), pulmonary atresia in six (28.5%), and severe tricuspid regurgitation in two (9.5%). Eleven out of 21 patients had biventricular physiology and eight had single-ventricle physiology. Bidirectional cavopulmonary anastomosis followed by a hemi-Mustard-Rastelli operation were planned for the remaining two patients. Twelve out of 18 patients with associated defects (66.6%) were operated and surgery was planned for three more patients (16.6%). The remaining three patients were scheduled for clinical follow-up. Arrhythmias developed in two (9.5%) patients on follow-up; ablation was performed in one of them and pacemaker implantation followed by cardiac resynchronization therapy was performed in the other. Two patients died during follow-up, one after a central shunt operation and the other preoperatively due to pneumonia and sepsis. SI-ccTGA is not a mirror image of situs solitus ccTGA (SS-ccTGA) due to important anatomic and physiologic differences between them. SI-ccTGA patients have a lower risk of tricuspid valve regurgitation than SS-ccTGA patients. The timing of clinical presentation of these patients mainly depends on the type and severity of the associated lesions, as in all subtypes of ccTGA.

15 July 2022 in Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
EEEmine Yurdakul Erturk
Emine Yurdakul Erturk
TKTaner Kasar
Taner Kasar
Amaç: Azollerin profilaksi veya tedavi amacıyla yaygın ve tekrarlayan kullanımı Candida albicans (C.albicans) türlerinde direnç gelişimine yol açmıştır. Gereç ve Yöntemler: Bu çalışmada, steril vücut sıvısı kültürlerinden izole edilen C.albicans izolatlarının flukonazol, itrakonazol ve vorikonazole in vitro direnç oranlarının belirlenmesi amaçlanmıştır. Tür düzeyinde tanımlama, geleneksel tanı yöntemleri ve BD Phoenix 100 (BD, ABD) otomatik tanımlama sistemi kullanılarak yapıldı. Antifungal duyarlılık testi, %2 glukoz içeren RPMI kullanılarak mikrodilüsyon yöntemiyle değerlendirildi. Triazoller olan flukonazol, itrakonazol ve vorikonazol için bulanıklığın belirgin (≥%50) olarak azaldığı kuyucuktaki konsantrasyon, MİK50 değeri olarak belirlendi. Çalışmada kontrol suş olarak C.albicans ATCC 90028 kullanıldı. Bulgular: C.albicans izolatlarının %88.2’si (n=45) yoğun bakım ünitelerinden alınan örneklerden izole edildi. Örneklerin 26 (%50.9)’sı yaş ortalaması 68.6±18.29 yıl olan kadın hastalardan, 25 (%49)’i yaş ortalaması 62.22±21.08 yıl olan erkek hastalardan alındı. İzolatların 48 (%94.1)’i kan,1 (%1.96)’i beyin omurilik sıvısı, 1 (%1.96)’i steril vücut sıvısı, 1(%1.96)’i peritoneal sıvı kültüründen tanımlandı. Antifungal duyarlılık test sonuçlarına göre türlerin 7 (%12.2)’si flukonazol, 14 (%27.4)’ü itrakonazol ve 5 (%9.8)’i vorikonazole dirençli bulundu. Toplam 6 (%11.7) örnekte ise çapraz dirence rastlandı. Sonuç: C.albicans izolatlarında triazollere direncin yanısıra diğer azollere karşı da çapraz direnç saptanmıştır. Bu nedenle uygun tedavi için antifungal duyarlılık test sonuçları dikkate alınmalıdır.